ROYAL BANK OF CANADA - RAIN THERAPEUTICS INC ownership

RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 58 filers reported holding RAIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of RAIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,0000.0%2,672
+67.7%
0.00%
Q2 2023$2,0001,593
+159200.0%
0.00%
Q1 2023$01
-50.0%
0.00%
Q4 2022$02
-91.7%
0.00%
Q3 2022$0
-100.0%
24
-97.5%
0.00%
Q1 2022$5,000
-89.1%
978
-72.7%
0.00%
Q4 2021$46,000
+283.3%
3,587
+338.0%
0.00%
Q3 2021$12,000
+33.3%
819
+35.8%
0.00%
Q2 2021$9,0006030.00%
Other shareholders
RAIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,571,379$7,967,0002.01%
Cormorant Asset Management, LP 2,326,660$11,796,0000.91%
BVF INC/IL 3,526,729$17,881,0000.72%
Boxer Capital, LLC 1,175,000$5,957,0000.31%
Perceptive Advisors 2,483,619$12,592,0000.25%
Logos Global Management LP 134,194$680,0000.09%
Lumina Fund Management LLC 6,000$30,0000.01%
Woodline Partners LP 119,700$607,0000.01%
Trexquant Investment LP 28,373$144,0000.01%
Alyeska Investment Group, L.P. 125,000$634,0000.01%
View complete list of RAIN THERAPEUTICS INC shareholders